Molina Healthcare MOH Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $10.8B-5.1% | $11.38B-0.9% | $11.48B+0.4% | $11.43B+2.5% | $11.15B+6.2% | ||
| $9.27B-8.5% | $10.14B+0.9% | $10.04B+2.2% | $9.83B+3.7% | $9.48B+5.3% | ||
| $779M-2.0% | $795M+9.1% | $729M+2.5% | $711M-8.1% | $774M+16.4% | ||
| $10.71B-7.1% | $11.54B+1.7% | $11.34B+2.6% | $11.05B+3.2% | $10.71B+5.9% | ||
| $83M— | —— | $137M-63.3% | $373M-13.9% | $433M+13.9% | ||
| 0.8%— | —— | 1.2%-2.1pp | 3.3%-0.6pp | 3.9%+0.3pp | ||
| $54M+3.8% | $52M+6.1% | $49M+2.1% | $48M+11.6% | $43M+26.5% | ||
| $22M-8.3% | $24M+9.1% | $22M0.0% | $22M-4.3% | $23M+4.5% | ||
| $29M— | —— | $88M-72.9% | $325M-16.7% | $390M+12.7% | ||
| $15M— | —— | $9M-87.1% | $70M-23.9% | $92M-3.2% | ||
| $14M— | —— | $79M-69.0% | $255M-14.4% | $298M+18.7% | ||
| 0.1%— | —— | 0.7%-1.5pp | 2.2%-0.4pp | 2.7%+0.3pp | ||
| $0.27— | —— | $1.51-68.2% | $4.75-12.8% | $5.45+22.5% | ||
| $122M— | —— | $182M-57.8% | $431M-10.4% | $481M+12.4% | ||
| 1.1%— | —— | 1.6%-2.2pp | 3.8%-0.5pp | 4.3%+0.2pp | ||
| $83M— | —— | $137M-63.3% | $373M-13.9% | $433M+13.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Molina Healthcare's revenue?
- Molina Healthcare (MOH) generated $45.1B in revenue over the trailing twelve months, up 7.7% year over year.
- Is Molina Healthcare profitable?
- Molina Healthcare reported $646.0M in net income over the trailing twelve months, a 2.0% net margin.
- What are Molina Healthcare's profit margins?
- Gross margin is 12.9% and operating margin is 3.0%, with a 2.0% net margin.
- What is Molina Healthcare's earnings per share?
- Molina Healthcare's diluted EPS over the trailing twelve months is $11.98.
- Where does Molina Healthcare's income statement data come from?
- Every line is extracted from Molina Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
